ASCO: Risks of Whole Brain Radiotx May Outweigh Benefits
Second study suggests new immunotherapy may benefit patients with glioblastoma
ASCO: MMR Deficiency Predicts Pembrolizumab Response
Findings may help doctors better choose patients to receive pembrolizumab (Keytruda)
Sleep Apnea Risk Found to Rise With PTSD Severity in Veterans
Researcher suggests OSA screening for vets presenting for PTSD treatment
ASCO: Rx Strategies Promising for CLL, Non-Hodgkin’s Lymphoma
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Smoke Exposure May Create Need for More Anesthesia
Effect seems to extend to patients exposed to secondhand smoke, as well as smokers
ASCO: Lymph Node Sx Doesn’t Benefit All Melanoma Patients
Second study supports new immunotherapy for enhanced survival in advanced melanoma
ASCO: Palbociclib Ups Survival in HR+ Metastatic Breast Cancer
Adding palbociclib to standard hormone therapy kept disease from progressing for nine months
ASCO: Greater Breast Tissue Removal Reduces Further Surgery
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer
Physician Intervention Doesn’t Cut Maternal Vaccine Hesitancy
Second study shows high PBE schools colocated with schools with elevated PME rates
May 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for May 2015. This roundup includes the latest...
